Linda Black, DVM, PhD

Dr. Linda Black, DVM, PhD, is Chief Executive Officer of Gallant and a founding member of the company, previously serving as President and Chief Scientific Officer. She brings extensive leadership experience across biotechnology, spanning corporate development, research and development, operations, and commercialization, with deep expertise in regenerative medicine and stem cell therapies for pets.

Prior to Gallant, she served as President and Chief Scientific Officer of Medicus Biosciences and as Vice President of Product Development at VetStem Biopharma, where she helped pioneer the first off-the-shelf stem cell therapies for dogs. Dr. Black has authored foundational research on adipose-derived stem cells and has led programs advancing these therapies to commercialization. She holds a DVM from the University of Wisconsin–Madison and a PhD in Cell and Molecular Biology from the University of Pennsylvania.